Analysis of IDH mutation, 1p/19q deletion, and PTEN loss delineates prognosis in clinical low-grade diffuse gliomas
Sabha, N., Knobbe, C. B., Maganti, M., Al Omar, S., Bernstein, M., Cairns, R., Cako, B., von Deimling, A., Capper, D., Mak, T. W., Kiehl, T.-R., Carvalho, P., Garrett, E., Perry, A., Zadeh, G., Guha,Volume:
16
Language:
english
Journal:
Neuro-Oncology
DOI:
10.1093/neuonc/not299
Date:
July, 2014
File:
PDF, 731 KB
english, 2014